Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Kian Behbakht

Concepts (457)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
48
2025
589
5.470
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
11
2025
132
1.580
 Why?
Endometrial Neoplasms
11
2025
205
1.140
 Why?
Peritoneal Neoplasms
7
2024
104
1.030
 Why?
Drug Resistance, Neoplasm
17
2024
881
1.010
 Why?
Cystadenocarcinoma, Serous
7
2025
84
0.990
 Why?
Genital Neoplasms, Female
6
2020
99
0.840
 Why?
Uterine Cervical Neoplasms
8
2017
269
0.830
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2020
1961
0.830
 Why?
Claudin-4
5
2025
17
0.760
 Why?
Biomarkers, Tumor
9
2025
1319
0.700
 Why?
Hysterectomy
4
2018
137
0.700
 Why?
Antineoplastic Agents
10
2023
2201
0.680
 Why?
Neoplasm Recurrence, Local
8
2025
1145
0.670
 Why?
Fallopian Tube Neoplasms
6
2024
19
0.670
 Why?
TNF-Related Apoptosis-Inducing Ligand
5
2017
54
0.610
 Why?
Gelatin
2
2016
56
0.560
 Why?
Neoplasms, Glandular and Epithelial
3
2015
52
0.550
 Why?
Thrombin
2
2016
167
0.540
 Why?
Models, Economic
1
2018
61
0.540
 Why?
Cell Line, Tumor
22
2025
3523
0.530
 Why?
Hyperthermia, Induced
1
2018
120
0.510
 Why?
Histone-Lysine N-Methyltransferase
3
2024
141
0.500
 Why?
Female
89
2025
78304
0.490
 Why?
Pelvic Infection
1
2016
6
0.480
 Why?
Homeodomain Proteins
3
2012
523
0.470
 Why?
Tissue Adhesives
1
2016
22
0.470
 Why?
Neoplastic Cells, Circulating
2
2017
80
0.450
 Why?
Cost-Benefit Analysis
1
2018
638
0.450
 Why?
Women
1
2015
50
0.430
 Why?
Genomic Instability
2
2025
67
0.430
 Why?
Sirolimus
2
2016
280
0.410
 Why?
Vagina
6
2016
201
0.380
 Why?
Humans
93
2025
144667
0.360
 Why?
Antibodies, Neoplasm
1
2012
34
0.360
 Why?
Middle Aged
50
2025
35971
0.360
 Why?
Health Knowledge, Attitudes, Practice
2
2015
1406
0.350
 Why?
Neoplasm Staging
15
2024
1465
0.340
 Why?
Cisplatin
2
2015
339
0.340
 Why?
Aged
38
2025
25955
0.330
 Why?
Aged, 80 and over
19
2025
8284
0.320
 Why?
Tumor Microenvironment
3
2025
729
0.310
 Why?
Apoptosis
8
2019
2397
0.310
 Why?
Pelvic Exenteration
1
2009
12
0.300
 Why?
Uterine Neoplasms
4
2019
96
0.300
 Why?
Leiomyosarcoma
3
2020
28
0.300
 Why?
Neoadjuvant Therapy
4
2020
464
0.290
 Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
3
2017
31
0.290
 Why?
Paclitaxel
3
2019
256
0.290
 Why?
Cytoreduction Surgical Procedures
2
2020
70
0.290
 Why?
Phthalazines
2
2019
63
0.290
 Why?
Robotic Surgical Procedures
3
2016
183
0.280
 Why?
Pyrimidines
3
2019
519
0.280
 Why?
Carcinoma, Endometrioid
3
2019
49
0.280
 Why?
Health Personnel
1
2015
746
0.280
 Why?
Carbazoles
1
2008
54
0.270
 Why?
Chemotherapy, Adjuvant
2
2020
427
0.270
 Why?
Gene Expression Regulation, Neoplastic
8
2025
1437
0.270
 Why?
Caffeine
1
2008
74
0.270
 Why?
Azepines
2
2019
106
0.260
 Why?
Papanicolaou Test
2
2004
35
0.260
 Why?
Vaginal Smears
2
2004
54
0.260
 Why?
Protein Kinase C
1
2008
250
0.250
 Why?
Adult
32
2025
40489
0.250
 Why?
Piperazines
2
2019
378
0.250
 Why?
Clinical Competence
1
2015
1237
0.250
 Why?
Postoperative Complications
6
2020
2950
0.230
 Why?
Hemostasis, Surgical
2
2016
25
0.230
 Why?
Tumor Escape
1
2025
50
0.220
 Why?
Immune Evasion
1
2025
62
0.220
 Why?
Laparotomy
2
2015
112
0.220
 Why?
Urban Health
1
2004
96
0.210
 Why?
Adenocarcinoma
4
2015
923
0.210
 Why?
Disease-Free Survival
7
2017
768
0.210
 Why?
Fallopian Tubes
1
2024
31
0.200
 Why?
Histocompatibility Antigens
2
2024
102
0.200
 Why?
Indoles
2
2025
504
0.200
 Why?
Genetic Therapy
2
2014
313
0.190
 Why?
Prognosis
9
2024
4312
0.190
 Why?
Uterine Cervical Dysplasia
2
2003
27
0.190
 Why?
Pyrazoles
2
2020
512
0.190
 Why?
Adenocarcinoma, Clear Cell
2
2021
14
0.180
 Why?
Lipids
2
2025
706
0.180
 Why?
Neoplasm Grading
5
2024
310
0.180
 Why?
Leiomyoma
2
2019
59
0.180
 Why?
Radiosurgery
1
2025
398
0.170
 Why?
Hospitals, Public
1
2001
30
0.170
 Why?
Piperidines
2
2019
219
0.160
 Why?
BRCA2 Protein
3
2019
68
0.160
 Why?
Hospitals, University
1
2001
176
0.160
 Why?
Vulvar Neoplasms
1
2020
13
0.160
 Why?
Cervix Uteri
3
2011
50
0.160
 Why?
Healthcare Disparities
2
2018
736
0.160
 Why?
Early Detection of Cancer
1
2025
472
0.160
 Why?
Epoxy Compounds
1
2020
31
0.160
 Why?
Mutation
5
2019
4081
0.150
 Why?
Carnitine O-Palmitoyltransferase
1
2020
49
0.150
 Why?
Rad51 Recombinase
1
2019
15
0.150
 Why?
Treatment Outcome
11
2020
11735
0.150
 Why?
Cell Movement
2
2016
959
0.150
 Why?
Up-Regulation
2
2020
848
0.150
 Why?
Vaccines, Conjugate
1
2019
59
0.150
 Why?
Enoxaparin
1
2020
68
0.150
 Why?
Machine Learning
1
2025
587
0.150
 Why?
Receptors, Adiponectin
1
2019
22
0.150
 Why?
Poly(ADP-ribose) Polymerases
1
2019
85
0.140
 Why?
Interleukin-12
2
2014
117
0.140
 Why?
Animals
15
2025
37948
0.140
 Why?
Sequence Analysis, RNA
2
2019
442
0.140
 Why?
Neoplasms
4
2017
2873
0.140
 Why?
CD8-Positive T-Lymphocytes
1
2024
915
0.140
 Why?
Pyridones
1
2020
201
0.140
 Why?
Cancer Vaccines
1
2019
160
0.140
 Why?
Lymph Node Excision
2
2020
173
0.140
 Why?
Mice
11
2025
18261
0.140
 Why?
Adjuvants, Immunologic
1
2019
245
0.140
 Why?
Cost Savings
1
2018
85
0.130
 Why?
Ovariectomy
2
2015
163
0.130
 Why?
Cell Growth Processes
2
2008
47
0.130
 Why?
Oncologists
1
2018
46
0.130
 Why?
Sarcoma
1
2020
203
0.130
 Why?
Patient Acceptance of Health Care
1
2004
881
0.130
 Why?
Dose-Response Relationship, Drug
4
2008
2019
0.130
 Why?
Antineoplastic Agents, Phytogenic
1
2019
176
0.130
 Why?
Aurora Kinase A
1
2017
61
0.130
 Why?
Leukocyte Common Antigens
1
2017
87
0.130
 Why?
Pregnancy Complications, Infectious
1
2002
431
0.130
 Why?
Anion Transport Proteins
1
2017
8
0.130
 Why?
Breast Neoplasms
4
2019
2365
0.130
 Why?
Salpingectomy
2
2015
15
0.120
 Why?
Sexual Dysfunctions, Psychological
1
2017
30
0.120
 Why?
Curettage
1
2016
8
0.120
 Why?
beta Catenin
1
2019
252
0.120
 Why?
Gestational Trophoblastic Disease
1
2016
6
0.120
 Why?
Fatty Acids
1
2020
454
0.120
 Why?
Keratins
1
2017
171
0.120
 Why?
Survival Rate
5
2020
2089
0.120
 Why?
Megestrol Acetate
1
2016
3
0.120
 Why?
Carcinoma, Neuroendocrine
1
2016
37
0.120
 Why?
Minority Groups
1
2018
283
0.120
 Why?
Neoplasms, Squamous Cell
1
1996
4
0.120
 Why?
Sexual Dysfunction, Physiological
1
2017
74
0.120
 Why?
Colony Count, Microbial
1
2016
123
0.120
 Why?
Gynecology
1
2018
178
0.120
 Why?
Standard of Care
1
2016
81
0.120
 Why?
Medroxyprogesterone Acetate
1
2015
33
0.120
 Why?
Risk Factors
6
2016
10796
0.120
 Why?
Adenoviridae
1
1996
199
0.120
 Why?
Venous Thromboembolism
1
2020
326
0.120
 Why?
Cell Survival
4
2025
1092
0.110
 Why?
Gene Expression Profiling
2
2019
1766
0.110
 Why?
Keratin-5
1
2015
44
0.110
 Why?
Brachytherapy
1
2016
133
0.110
 Why?
Molecular Targeted Therapy
1
2018
437
0.110
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2017
973
0.110
 Why?
Tamoxifen
1
2016
191
0.110
 Why?
Immunohistochemistry
3
2016
1705
0.110
 Why?
Tretinoin
1
1996
124
0.110
 Why?
Chemoradiotherapy
1
2016
239
0.110
 Why?
Cell Proliferation
5
2024
2489
0.110
 Why?
Anticoagulants
1
2020
729
0.110
 Why?
Combined Modality Therapy
4
2020
1268
0.110
 Why?
CA-125 Antigen
2
2008
13
0.110
 Why?
Abdominal Abscess
1
2014
25
0.110
 Why?
Antineoplastic Agents, Hormonal
1
2015
192
0.100
 Why?
Mice, SCID
2
2012
368
0.100
 Why?
Xenograft Model Antitumor Assays
3
2024
925
0.100
 Why?
Cytokines
1
2002
2045
0.100
 Why?
Endometrium
1
2014
59
0.100
 Why?
Glycoproteins
1
2015
353
0.100
 Why?
Kaplan-Meier Estimate
4
2020
967
0.100
 Why?
Surgeons
1
2018
341
0.100
 Why?
Interpersonal Relations
1
2017
399
0.100
 Why?
Lipid Metabolism
1
2017
524
0.100
 Why?
Cell Cycle
2
2025
595
0.100
 Why?
Case-Control Studies
5
2025
3603
0.100
 Why?
Immunotherapy
1
2018
662
0.100
 Why?
Double-Blind Method
4
2025
2033
0.100
 Why?
Quality of Health Care
1
2018
692
0.100
 Why?
Reoperation
1
2016
624
0.100
 Why?
Transforming Growth Factor beta
1
1996
475
0.100
 Why?
Proto-Oncogene Proteins c-akt
2
2016
435
0.100
 Why?
Pelvic Neoplasms
1
2013
24
0.100
 Why?
Genes, Tumor Suppressor
3
1998
85
0.100
 Why?
Plasmids
1
2014
375
0.090
 Why?
Models, Biological
3
2019
1811
0.090
 Why?
Antigens, CD
1
2015
552
0.090
 Why?
Young Adult
5
2020
14122
0.090
 Why?
Gardnerella vaginalis
2
2002
3
0.090
 Why?
Cell Division
2
2008
753
0.090
 Why?
Antibody Specificity
1
2012
178
0.090
 Why?
Neoplastic Stem Cells
1
2015
407
0.090
 Why?
Endocrine Gland Neoplasms
1
2011
1
0.090
 Why?
Transplantation, Heterologous
1
2012
169
0.090
 Why?
RNA, Messenger
2
2012
2815
0.090
 Why?
Escherichia coli
1
2016
854
0.090
 Why?
RNA, Small Interfering
3
2020
631
0.080
 Why?
Cyclin D1
1
2011
63
0.080
 Why?
Drug Synergism
2
2011
352
0.080
 Why?
Proteasome Inhibitors
1
2011
38
0.080
 Why?
MicroRNAs
1
2017
689
0.080
 Why?
DNA
1
2017
1447
0.080
 Why?
Adenocarcinoma, Mucinous
1
2011
76
0.080
 Why?
Transfection
2
2007
924
0.080
 Why?
Cadherins
1
2011
200
0.080
 Why?
Peptides
1
2015
989
0.080
 Why?
Neoplasm Invasiveness
3
2016
503
0.080
 Why?
Age Factors
5
2016
3329
0.070
 Why?
Lymphoma
1
2011
233
0.070
 Why?
Inflammation
1
2020
2870
0.070
 Why?
Skin Transplantation
1
2009
85
0.070
 Why?
Anastomosis, Surgical
1
2009
161
0.070
 Why?
Urokinase-Type Plasminogen Activator
1
2008
25
0.070
 Why?
Papillomaviridae
2
2002
114
0.070
 Why?
Adaptor Proteins, Signal Transducing
1
2011
426
0.070
 Why?
G2 Phase
1
2008
39
0.070
 Why?
Adolescent
5
2020
22409
0.070
 Why?
Radiation-Protective Agents
1
2008
17
0.070
 Why?
Rectum
1
2009
183
0.070
 Why?
TOR Serine-Threonine Kinases
1
2011
452
0.070
 Why?
Heterografts
2
2019
143
0.070
 Why?
Genes, BRCA1
2
1998
45
0.060
 Why?
Models, Statistical
1
2011
677
0.060
 Why?
Microsatellite Instability
2
2019
55
0.060
 Why?
Urinary Bladder
1
2009
192
0.060
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2019
108
0.060
 Why?
Cell Culture Techniques
2
2020
372
0.060
 Why?
Cysteine
1
2008
207
0.060
 Why?
Tumor Suppressor Protein p53
3
2019
532
0.060
 Why?
PTEN Phosphohydrolase
2
2019
164
0.060
 Why?
Gynecologic Surgical Procedures
2
2020
66
0.060
 Why?
Models, Animal
1
2008
393
0.060
 Why?
Adenosarcoma
2
2005
2
0.060
 Why?
Proportional Hazards Models
3
2020
1322
0.060
 Why?
Follow-Up Studies
4
2020
5414
0.060
 Why?
Signal Transduction
4
2012
5185
0.060
 Why?
Indazoles
2
2019
82
0.060
 Why?
Polymerase Chain Reaction
4
2002
1047
0.060
 Why?
Colposcopy
2
2003
18
0.060
 Why?
Maintenance Chemotherapy
1
2025
42
0.060
 Why?
Intestinal Neoplasms
1
2005
30
0.060
 Why?
Cell Count
2
2015
320
0.060
 Why?
Ovary
1
2007
226
0.060
 Why?
Neoplasm Proteins
3
1998
441
0.060
 Why?
Length of Stay
3
2015
1339
0.060
 Why?
Retrospective Studies
6
2020
17149
0.060
 Why?
Sexual Behavior
1
2009
493
0.060
 Why?
Ultraviolet Rays
1
2008
384
0.050
 Why?
Germ-Line Mutation
2
1996
176
0.050
 Why?
Chicago
1
2004
62
0.050
 Why?
Tumor Cells, Cultured
2
1996
881
0.050
 Why?
Peptide Fragments
1
2008
691
0.050
 Why?
Disease Progression
3
2019
2847
0.050
 Why?
United States
5
2022
16018
0.050
 Why?
Antioxidants
1
2008
546
0.050
 Why?
Transcription Factors
4
2011
1726
0.050
 Why?
Blood Loss, Surgical
2
2015
110
0.050
 Why?
Survival Analysis
4
2020
1370
0.050
 Why?
Activating Transcription Factor 6
1
2023
19
0.050
 Why?
Receptors, Estrogen
2
2015
400
0.050
 Why?
Transcription Factor AP-1
1
2023
79
0.050
 Why?
Women's Health
1
2004
307
0.050
 Why?
X-ray Repair Cross Complementing Protein 1
1
2022
14
0.050
 Why?
Neoplasm Metastasis
2
2015
691
0.040
 Why?
Gene Expression
1
2007
1476
0.040
 Why?
Trichomonas vaginalis
1
2002
11
0.040
 Why?
Vaginal Neoplasms
1
2001
19
0.040
 Why?
Yeasts
1
2002
51
0.040
 Why?
Phosphatidylinositol 3-Kinases
2
2016
380
0.040
 Why?
Vaginosis, Bacterial
1
2001
10
0.040
 Why?
Vaginal Diseases
1
2001
18
0.040
 Why?
Risk Assessment
3
2016
3729
0.040
 Why?
Medical Oncology
1
2024
331
0.040
 Why?
Cell Nucleus
1
2025
592
0.040
 Why?
Endometriosis
1
2001
57
0.040
 Why?
DNA, Neoplasm
2
1998
158
0.040
 Why?
Epithelial Cells
1
2007
1106
0.040
 Why?
DNA Primers
1
2002
507
0.040
 Why?
Vulvectomy
1
2020
2
0.040
 Why?
Pregnancy
3
2016
7122
0.040
 Why?
Dermatofibrosarcoma
1
2020
7
0.040
 Why?
Histiocytoma, Malignant Fibrous
1
2020
5
0.040
 Why?
Quality of Life
2
2025
3183
0.040
 Why?
Hospitals, Urban
1
2001
143
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2020
50
0.040
 Why?
Medically Uninsured
1
2001
129
0.040
 Why?
Liposarcoma
1
2020
31
0.040
 Why?
Disease Models, Animal
2
2024
4539
0.040
 Why?
Alleles
3
2017
886
0.040
 Why?
Databases, Factual
2
2016
1494
0.040
 Why?
Anoikis
1
2020
30
0.040
 Why?
Hemocyanins
1
2019
60
0.040
 Why?
Interleukin-10
1
2002
310
0.040
 Why?
Rhabdomyosarcoma
1
2020
64
0.040
 Why?
Chitinase-3-Like Protein 1
1
2019
18
0.040
 Why?
Enzyme-Linked Immunosorbent Assay
1
2002
835
0.040
 Why?
Diagnosis, Differential
2
2019
1501
0.040
 Why?
DNA Repair
1
2022
256
0.040
 Why?
Prospective Studies
4
2016
7994
0.040
 Why?
Logistic Models
1
2004
2114
0.040
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2019
27
0.040
 Why?
Radiotherapy
1
2020
205
0.040
 Why?
SEER Program
1
2020
226
0.040
 Why?
Intramolecular Oxidoreductases
1
2019
65
0.040
 Why?
Poly-ADP-Ribose Binding Proteins
1
2019
35
0.040
 Why?
DNA Polymerase II
1
2019
35
0.040
 Why?
Lymphatic Metastasis
1
2020
334
0.040
 Why?
DNA Damage
1
2022
430
0.040
 Why?
Gene Knockdown Techniques
1
2020
334
0.040
 Why?
Chromosomes, Human, Pair 7
1
1998
17
0.040
 Why?
Cell Cycle Checkpoints
1
2019
98
0.040
 Why?
Cytoskeletal Proteins
1
2019
155
0.040
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2019
138
0.030
 Why?
Microtubule-Associated Proteins
1
2019
195
0.030
 Why?
Mitosis
1
2019
200
0.030
 Why?
Interleukin-1
1
2002
961
0.030
 Why?
AMP-Activated Protein Kinases
1
2019
191
0.030
 Why?
Europe
1
2019
419
0.030
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
1998
40
0.030
 Why?
Interleukin-6
1
2002
770
0.030
 Why?
Image Cytometry
1
2017
11
0.030
 Why?
Wnt Signaling Pathway
1
2019
210
0.030
 Why?
Chromosomes, Human, Pair 14
1
1997
22
0.030
 Why?
Ganciclovir
1
1996
53
0.030
 Why?
Chromosome Deletion
1
1997
124
0.030
 Why?
Hospitals, Private
1
2016
12
0.030
 Why?
Health Facility Size
1
2016
13
0.030
 Why?
Socioeconomic Factors
1
2001
1322
0.030
 Why?
Mass Spectrometry
1
2019
743
0.030
 Why?
Chorionic Gonadotropin
1
2016
77
0.030
 Why?
Cell Separation
1
2017
303
0.030
 Why?
Oxidation-Reduction
1
2020
1078
0.030
 Why?
Ifosfamide
1
1996
39
0.030
 Why?
AC133 Antigen
1
2015
20
0.030
 Why?
Cell Line, Transformed
1
1996
138
0.030
 Why?
Cell Differentiation
2
2011
2037
0.030
 Why?
Time Factors
2
2019
7140
0.030
 Why?
Tissue Array Analysis
1
2015
49
0.030
 Why?
Hospital Charges
1
1996
46
0.030
 Why?
Hospitals, Teaching
1
2016
119
0.030
 Why?
Caspase 3
1
2016
234
0.030
 Why?
Marriage
1
2017
122
0.030
 Why?
Cystadenocarcinoma, Papillary
1
1995
4
0.030
 Why?
Antigens, Neoplasm
1
2017
272
0.030
 Why?
Carboplatin
1
1996
161
0.030
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2015
68
0.030
 Why?
Tumor Burden
1
2016
324
0.030
 Why?
Ileus
1
2015
13
0.030
 Why?
RNA-Binding Proteins
1
2019
461
0.030
 Why?
DNA Mismatch Repair
1
2015
53
0.030
 Why?
Genes, p53
1
1995
67
0.030
 Why?
Cell Cycle Proteins
1
2019
628
0.030
 Why?
Disease Management
1
2019
650
0.030
 Why?
Urinary Retention
1
2015
24
0.030
 Why?
Income
1
2016
201
0.030
 Why?
Female Urogenital Diseases
1
2014
7
0.030
 Why?
RNA Interference
1
2016
473
0.030
 Why?
Taxoids
1
2015
116
0.030
 Why?
Multivariate Analysis
2
1996
1537
0.030
 Why?
Morbidity
1
2015
322
0.030
 Why?
Receptors, Androgen
1
2015
148
0.030
 Why?
Elective Surgical Procedures
1
2016
201
0.030
 Why?
Drug Administration Schedule
1
2016
779
0.030
 Why?
Reference Values
1
1996
794
0.030
 Why?
Blood Volume
1
2014
65
0.030
 Why?
Sensitivity and Specificity
1
2019
1995
0.030
 Why?
Intraoperative Complications
1
2015
157
0.030
 Why?
Infusions, Parenteral
1
2014
47
0.030
 Why?
Bevacizumab
1
2015
168
0.030
 Why?
Point Mutation
1
1995
242
0.030
 Why?
Polyethyleneimine
1
2014
19
0.030
 Why?
Bleomycin
1
1996
253
0.030
 Why?
Receptors, Progesterone
1
2015
243
0.030
 Why?
Histones
1
2019
663
0.030
 Why?
DNA, Viral
1
1996
357
0.030
 Why?
Hemostatics
1
2014
60
0.030
 Why?
Pelvis
1
2015
126
0.030
 Why?
Tumor Suppressor Proteins
1
2016
319
0.020
 Why?
Deoxycytidine
1
2015
222
0.020
 Why?
Drainage
1
2014
184
0.020
 Why?
Insurance, Health
1
2016
308
0.020
 Why?
Anemia
1
2015
189
0.020
 Why?
Thrombocytopenia
1
2015
202
0.020
 Why?
Urban Population
1
2016
493
0.020
 Why?
Preoperative Care
1
2015
379
0.020
 Why?
Polymorphism, Single-Stranded Conformational
3
1998
26
0.020
 Why?
Gene Transfer Techniques
1
2014
186
0.020
 Why?
Patient Readmission
1
2018
765
0.020
 Why?
Membrane Proteins
1
2019
1159
0.020
 Why?
Ultrasonography
1
2016
776
0.020
 Why?
Biomarkers
1
2024
4261
0.020
 Why?
Linear Models
1
1994
845
0.020
 Why?
Referral and Consultation
1
2018
852
0.020
 Why?
Cholesterol
1
2014
404
0.020
 Why?
Analysis of Variance
1
1994
1301
0.020
 Why?
Zinc Finger E-box-Binding Homeobox 1
1
2011
21
0.020
 Why?
Perioperative Period
1
2011
70
0.020
 Why?
Mutant Proteins
1
2011
104
0.020
 Why?
DNA Fragmentation
1
2011
39
0.020
 Why?
Risk Reduction Behavior
1
2013
215
0.020
 Why?
Protein Kinase Inhibitors
1
2017
971
0.020
 Why?
Comorbidity
1
2016
1652
0.020
 Why?
Rural Population
1
2016
657
0.020
 Why?
Fas Ligand Protein
1
2011
60
0.020
 Why?
Neovascularization, Pathologic
1
2012
284
0.020
 Why?
Hyperplasia
1
2011
177
0.020
 Why?
Neoplasm Transplantation
1
2011
246
0.020
 Why?
Tomography, X-Ray Computed
2
2014
2754
0.020
 Why?
Polymorphism, Single Nucleotide
1
2017
2137
0.020
 Why?
Epithelial-Mesenchymal Transition
1
2011
211
0.020
 Why?
Administration, Oral
1
2012
851
0.020
 Why?
Regression Analysis
1
2011
998
0.020
 Why?
Polyethylene Glycols
1
2014
652
0.020
 Why?
Receptors, Urokinase Plasminogen Activator
1
2008
15
0.020
 Why?
Pregnancy Complications
1
2014
586
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2015
990
0.020
 Why?
Anti-Bacterial Agents
2
2014
1928
0.020
 Why?
Blotting, Western
1
2011
1161
0.020
 Why?
Placebos
1
2008
193
0.020
 Why?
Injections, Subcutaneous
1
2008
168
0.020
 Why?
Patient Discharge
1
2015
985
0.020
 Why?
Mice, Hairless
1
2008
47
0.020
 Why?
Enzyme Inhibitors
1
2011
820
0.020
 Why?
Sulfonamides
1
2011
579
0.020
 Why?
Molecular Sequence Data
3
1996
2909
0.020
 Why?
Quality Improvement
1
2015
1287
0.020
 Why?
Chromosome Mapping
2
1998
507
0.020
 Why?
Genetic Markers
2
1998
332
0.020
 Why?
Receptors, Cell Surface
1
2008
370
0.010
 Why?
Frameshift Mutation
2
1996
30
0.010
 Why?
Gene Deletion
2
1998
392
0.010
 Why?
Carcinosarcoma
1
2005
23
0.010
 Why?
Cross-Sectional Studies
1
2017
5870
0.010
 Why?
DNA Mutational Analysis
2
1996
409
0.010
 Why?
Cohort Studies
1
2015
5957
0.010
 Why?
Colorado
1
2014
4558
0.010
 Why?
Severity of Illness Index
1
2011
2922
0.010
 Why?
Obesity
1
2016
3070
0.010
 Why?
Base Sequence
2
1996
2177
0.010
 Why?
Electrophoresis, Gel, Pulsed-Field
1
2001
23
0.010
 Why?
Metronidazole
1
2001
20
0.010
 Why?
Genes, rRNA
1
2001
42
0.010
 Why?
Microbial Sensitivity Tests
1
2001
373
0.010
 Why?
DNA, Bacterial
1
2001
347
0.010
 Why?
RNA, Ribosomal, 16S
1
2001
564
0.010
 Why?
Loss of Heterozygosity
1
1998
52
0.010
 Why?
Microsatellite Repeats
1
1998
155
0.010
 Why?
Actuarial Analysis
1
1996
16
0.010
 Why?
Ecosystem
1
2001
591
0.010
 Why?
Genes, Neoplasm
1
1995
25
0.010
 Why?
BRCA1 Protein
1
1995
82
0.010
 Why?
Sequence Analysis, DNA
1
1998
828
0.010
 Why?
Age of Onset
1
1996
551
0.010
 Why?
Introns
1
1995
255
0.010
 Why?
Exons
1
1995
362
0.010
 Why?
Amino Acid Sequence
1
1995
2136
0.010
 Why?
Male
1
2017
72431
0.000
 Why?
Behbakht's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (457) concept(s)
_
Co-Authors Expand Description
See all (55) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)